Pharmaroth Labs Inc (ROTH) 0.0033 $ROTH
PharmaRoth Labs Announces Integration of HSBC Credit Facilities
Marketwired - Tue May 03, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer, and distributor of Sucanon(R), an oral Type-II Diabetes treatment, today announced that it has successfully closed on the integration of its "Automatic Invoice Discounting" credit facilities with HSBC Mexico S.A. ("HSBC"
. The credit facilities allow the company to receive payment through HSBC, derived from both new and existing purchase orders.
PharmaRoth Labs Announces New Sales Agreement in India
Marketwired - Mon Nov 02, 7:31AM CST
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer, and distributor of Sucanon(R), an oral Type-II Diabetes treatment, announced today that it has signed an exclusive distribution and sales agreement with Canagen Pharmaceuticals for the country of India. The agreement gives Canagen exclusive rights to sell and distribute Sucanon(R) throughout India for 5 years, and in total represents $85 million over those years in gross sales.
PharmaRoth Labs Announces Approval of Sucanon(R) in Canada
Marketwired - Tue Oct 13, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, announced today that Sucanon(R) has been approved for over the counter sales in Canada as a natural health product. The approval comes through Health Canada, the regulating health-care agency of Canada.
PharmaRoth Labs Announces Follow-On Order From International Pharmacy Retailer
Marketwired - Tue Sep 22, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH) the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, announced today that the Company has received an additional order from its Mexican distributor, Marcas de Renombre. The order amount is for $80,000, which is in additional to the $80,000 order that was previously announced, placing Sucanon(R) on shelves at Farmacias de Similares, a large retailer with over 5,000 stores throughout Mexico, Guatamala, and Chile.
PharmaRoth Labs Receives Large Purchase Order
Marketwired - Tue Sep 08, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, has received an additional order from its Mexican distributor Marcus De Renombre for a major retail chain in Mexico. The order is for $80,000 and represents the largest single purchase order in the company's history. The order is for Farmacias de Similares, a retailer with over 5,000 stores throughout Mexico, Guatemala, and Chile.
PharmaRoth Labs Announces Endorsement by Mexican Diabetes Association
Marketwired - Wed Mar 25, 8:02AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, is proud to announce that the Mexican Diabetes Association has endorsed Sucanon(R) as a safe and effective alternative treatment for pre-diabetic and recently diagnosed patients. The Mexican Association of Diabetes, AC, (AMD) is a nonprofit institution that provides care, education and training on diabetes care to people living with this disease and their families, in order to prevent the occurrence of the associated complications and provide them a better quality of life.
PharmaRoth Labs Announces Integration of HSBC Credit Facilities
Marketwired - Tue May 03, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer, and distributor of Sucanon(R), an oral Type-II Diabetes treatment, today announced that it has successfully closed on the integration of its "Automatic Invoice Discounting" credit facilities with HSBC Mexico S.A. ("HSBC"
. The credit facilities allow the company to receive payment through HSBC, derived from both new and existing purchase orders. PharmaRoth Labs Announces New Sales Agreement in India
Marketwired - Mon Nov 02, 7:31AM CST
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer, and distributor of Sucanon(R), an oral Type-II Diabetes treatment, announced today that it has signed an exclusive distribution and sales agreement with Canagen Pharmaceuticals for the country of India. The agreement gives Canagen exclusive rights to sell and distribute Sucanon(R) throughout India for 5 years, and in total represents $85 million over those years in gross sales.
PharmaRoth Labs Announces Approval of Sucanon(R) in Canada
Marketwired - Tue Oct 13, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, announced today that Sucanon(R) has been approved for over the counter sales in Canada as a natural health product. The approval comes through Health Canada, the regulating health-care agency of Canada.
PharmaRoth Labs Announces Follow-On Order From International Pharmacy Retailer
Marketwired - Tue Sep 22, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH) the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, announced today that the Company has received an additional order from its Mexican distributor, Marcas de Renombre. The order amount is for $80,000, which is in additional to the $80,000 order that was previously announced, placing Sucanon(R) on shelves at Farmacias de Similares, a large retailer with over 5,000 stores throughout Mexico, Guatamala, and Chile.
PharmaRoth Labs Receives Large Purchase Order
Marketwired - Tue Sep 08, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, has received an additional order from its Mexican distributor Marcus De Renombre for a major retail chain in Mexico. The order is for $80,000 and represents the largest single purchase order in the company's history. The order is for Farmacias de Similares, a retailer with over 5,000 stores throughout Mexico, Guatemala, and Chile.
PharmaRoth Labs Announces Endorsement by Mexican Diabetes Association
Marketwired - Wed Mar 25, 8:02AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, is proud to announce that the Mexican Diabetes Association has endorsed Sucanon(R) as a safe and effective alternative treatment for pre-diabetic and recently diagnosed patients. The Mexican Association of Diabetes, AC, (AMD) is a nonprofit institution that provides care, education and training on diabetes care to people living with this disease and their families, in order to prevent the occurrence of the associated complications and provide them a better quality of life.
